Skip to content
777 Sourcing.

Capability

treatment response prediction

Suppliers
1
States & provinces
1
Countries
1

1 treatment response prediction supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

ADJUVANT GENOMICS, INC

DALLAS, TX

Adjuvant Genomics provides genomic insights for non-small cell lung cancer (NSCLC) patients, empowering oncologists with a risk and treatment response score. The company identifies high-risk patients more likely to experience cancer recurrence, predicts responsiveness to adjuvant chemotherapy, and supports faster transition to alternative adjuvant therapies. It aims to improve prognosis and treatment outcomes for patients with Stage 1 & 2 NSCLC.

genomic assayrisk scoring

Compiled from public sources

Related capabilities

Other processes offered by the shops that list treatment response prediction.

Browse all capabilities